期刊
EXPERT OPINION ON THERAPEUTIC TARGETS
卷 17, 期 7, 页码 773-779出版社
TAYLOR & FRANCIS LTD
DOI: 10.1517/14728222.2013.789502
关键词
alanine aminotransferase; aspartate aminotransferase; insulin resistance; metabolic syndrome; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis; triglycerides
资金
- NIH [DK076852, DK082451]
Introduction: Nonalcoholic fatty liver disease (NAFLD) is a serious public health problem. It is now estimated to affect 30% of adults and about 10% of children in the U.S. Hispanics are disproportionably affected with not only higher rates of NAFLD but also more severe disease. Treatment options are currently limited. Areas covered: In this review, we will focus on a series of novel findings related to the pathobiology of liver damage in nonalcoholic steatohepatitis (NASH) that are attractive targets for development of novel therapeutic strategies for human NASH. In particular, we will discuss four different areas due to their novelty and growing importance including nnicroparticles, the inflammasomes, gut-liver axis and dietary lipids. Expert opinion: There is an urgent need to develop novel safe and effective therapies for the growing NAFLD epidemic. The data discussed in this article provide strong rational to think out of the box when considering novel therapeutic targets for patients with NAFLD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据